Home › Research › Topics › dna-methylation
dna-methylation
17 studies tagged dna-methylation, dated 2004-05-01 to 2022-10-31. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The DNA Methylation in Neurological Diseases 2022-10-31
- Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease 2020-11-30
- Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease 2019-03-21
Studies
17 studies carry this tag.
Date range
2004 to 2022
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 2
- Brain, behavior, and immunity 2
- Acta neuropathologica 1
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 1
15 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
DNA methylation is critical for the normal development and functioning of the human brain, such as the proliferation and differentiation of neural stem cells, synaptic plasticity, neuronal reparation, learning, and memory.
-
DNA methylation differences in Alzheimer's disease (AD) have been reported.
-
Our study represents the first epigenome-wide association study of both DNA methylation and hydroxymethylation in Alzheimer's disease entorhinal cortex.
-
Late-onset Alzheimer's disease (AD) is a complex age-related neurodegenerative disorder that likely involves epigenetic factors.
-
Our data highlight the complex interplay between disease, age and cell-type-specific methylation changes in AD risk genes thus offering new perspectives for the validation and interpretation of large EWAS results.
-
Associations are present between environmental risk factors for AD and age acceleration.
-
Ageing, a leading cause of the decline/deficits in human learning, memory, and cognitive abilities, is a major risk factor for age-associated neurodegenerative disorders such as Alzheimer’s disease.
-
We present robust evidence for elevated DNA methylation associated with Alzheimer's disease neuropathology spanning the HOXA gene cluster on chromosome 7.
-
HPA axis genes implicated in glucocorticoid regulation play an important role in regulating the physiological impact of social and environmental stress, and have become a focal point for investigating the role of glucocorticoid regulation in the etiology of disease.
-
Research over the years has shown that causes of Alzheimer's disease are not well understood, but over the past years, the involvement of epigenetic mechanisms in the developing memory formation either under pathological or physiological conditions has become clear.
-
Our results indicate that cycles of DNA methylation contribute to the regulation of BMAL1 rhythms in the brain.
-
Changes in epigenetic marks may help explain the late onset of Alzheimer's disease (AD).
-
Epigenetic alterations represent a sort of functional modifications related to the genome that are not responsible for changes in the nucleotide sequence.
-
The central nervous system has a pattern of gene expression that is closely regulated with respect to functional and anatomical regions.
-
Evidence supports a role for epigenetic mechanisms in the pathogenesis of late-onset Alzheimer's disease (LOAD), but little has been done on a genome-wide scale to identify potential sites involved in disease.
-
Epigenetics is believed to play a role in Alzheimer's disease (AD).
-
Fine-tuning of neuronal connections during development is regulated through environmental interactions.